animal models for neurological disorders
HuaTeng Biotechnology provides a specialized portfolio of animal models for neurological disorders. Our platform encompasses a wide spectrum of established procedures—from complex cerebrovascular injury and neurodegenerative disease models to behavioral and functional assessments. With robust capabilities in neurosurgery, molecular profiling, and in vivo phenotyping, we deliver reliable and translatable models to accelerate your neuroscience research.
|
Focal Cerebral Ischemia Model |
• Permanent MCAO: Via electrocautery or microclip occlusion of the MCA. reperfusion. |
|
Cerebral Hemorrhage Model |
• Collagenase Model: Intrastriatal injection of bacterial collagenase. parenchyma. |
|
Traumatic Brain Injury Model |
• Controlled Cortical Impact (CCI): A pneumatic or electromagnetic impactor is used. |
|
Hydrocephalus Model |
• Kaolin-Induced: Injection of kaolin into the cisterna magna to obstruct CSF flow. |
|
Brain Edema Model |
• Water Intoxication Model: Combined with vasopressin administration to induce cytotoxic edema. |
|
Alzheimer’s Disease (AD) Model |
• Transgenic Models: APP/PS1, 5xFAD mice. preformed fibrils. amnesia for cognitive screening. |
|
Parkinson's Disease (PD) Model |
• Neurotoxin Models: MPTP or 6-OHDA injection. preformed fibrils. (e.g., A53T). |
|
Hepatic Encephalopathy Model |
• Acute Model: Thioacetamide (TAA) injection. |
|
Autism Spectrum Disorder (ASD) Model |
• Prenatal VPA Exposure. |
|
Depression Model |
• Chronic Unpredictable Mild Stress (CUMS). |
|
Chronic Alcoholism Model |
• Chronic Intermittent Ethanol Vapor Exposure. |
|
Migraine Model |
• Inflammatory Soup Application to the dura mater. |
|
Chemotherapy-Induced Peripheral Neuropathy Model |
Repeated administration of Paclitaxel, Oxaliplatin, or Vincristine. |
|
Spinal Cord Injury Model |
• Contusion Model. |
|
Peripheral Nerve Injury Model |
• Sciatic Nerve Crush (axonotmesis). |
|
Experimental Autoimmune Encephalomyelitis Model |
Immunization with MOG₃₅₅₅ in CFA, supplemented with pertussis toxin. |
|
Pre-Eclampsia Model |
• RUPP Model: Surgical constriction of uterine arteries in pregnant rats. -angiogenic factors. |
|
Sleep Deprivation Model |
• Platform/Flowerpot Method (REM sleep deprivation). |
|
Glioma Model |
• Orthotopic Xenograft of human cell lines (e.g., U87). |
Global Compliance: AAALAC-accredited facilities with IACUC oversight, aligned with EU Directive 2010/63/EU and USDA standards—ensuring full regulatory acceptance across major markets.
Advanced Imaging Capabilities: Integrated platforms including DSA, IVUS, angiography and micro-CT, enabling real-time evaluation of device performance and in vivo outcomes.
Custom Model Development: Species-specific animal models tailored to complex disease conditions, improving translational relevance and clinical predictability.
Integrated Histopathology Suite: SEM and TEM analysis supported by GLP-grade reporting, enabling seamless submission to PMDA, CE Mark and global regulatory authorities.